GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.
During this webinar, we’ll explore a balanced, more intentional approach to GLP-1 management — one that goes beyond cost-shifting to focus on evidence-based prescribing, member engagement and sustainable outcomes. We’ll discuss:
- How Quantum Health’s new model ensures the right members start GLP-1 therapy through clinically guided readiness assessments and targeted support
- What self-insured employers can do to balance cost control with member outcomes in this rapidly evolving market
- How a human-centered, behavior-first strategy leads to long-term cost savings
- How to successfully graduate members from GLP-1s and onto sustainable, lower-cost strategies
Speakers
Quantum Health
Quantum Health
Vida Health
More like this
Transforming Care Decisions Through Data and Navigation
Quantum Health delivers real-time navigation and care coordination at critical decision points. Embold Health provides independent provider-quality analytics that identify top-performing physicians across specialties.
Learn more
Healthcare Navigation ROI: What's Real, What's Not and What Matters Now
Employers are under more pressure than ever to prove the value of their healthcare spend. Too often, ROI from navigation is poorly defined, inconsistently measured or based on minimal data.
Learn more
The Hidden Cost of Pain for Employers
Chronic pain may be costing your organization more than you think. This Pain Awareness Month, Quantum Health, Hinge Health and Oshi Health explore a smarter way forward.
Learn more